{"id":22475,"date":"2021-07-14T06:30:10","date_gmt":"2021-07-14T12:30:10","guid":{"rendered":"https:\/\/www.igssgt.org\/noticias\/?p=22475"},"modified":"2021-07-14T18:54:02","modified_gmt":"2021-07-15T00:54:02","slug":"el-igss-convoca-a-ofertar-el-medicamento-atezolizumab-concentrado-para-solucion-1200-mg-20ml-y-vial-con-20-ml-nog-14553546","status":"publish","type":"post","link":"https:\/\/www.igssgt.org\/noticias\/2021\/07\/14\/el-igss-convoca-a-ofertar-el-medicamento-atezolizumab-concentrado-para-solucion-1200-mg-20ml-y-vial-con-20-ml-nog-14553546\/","title":{"rendered":"El IGSS convoca a ofertar el medicamento Atezolizumab concentrado para soluci\u00f3n 1,200 MG\/20ML y vial con 20 ML, NOG 14553546"},"content":{"rendered":"\n<h3>Requerido para la Unidad de Consulta Externa de Enfermedades<\/h3>\n<h4>Recepci\u00f3n de ofertas 24 de agosto de 2021 a las 10:00 horas<\/h4>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-22476 \" src=\"\/wp-content\/uploads\/sites\/5\/2021\/07\/Convocatoria-IGSS-medicamento-atezolizumab-NOG-14553546-2021.png\" alt=\"\" width=\"564\" height=\"683\" srcset=\"\/wp-content\/uploads\/sites\/5\/2021\/07\/Convocatoria-IGSS-medicamento-atezolizumab-NOG-14553546-2021.png 491w, \/wp-content\/uploads\/sites\/5\/2021\/07\/Convocatoria-IGSS-medicamento-atezolizumab-NOG-14553546-2021-248x300.png 248w, \/wp-content\/uploads\/sites\/5\/2021\/07\/Convocatoria-IGSS-medicamento-atezolizumab-NOG-14553546-2021-347x420.png 347w, \/wp-content\/uploads\/sites\/5\/2021\/07\/Convocatoria-IGSS-medicamento-atezolizumab-NOG-14553546-2021-382x462.png 382w\" sizes=\"auto, (max-width: 564px) 100vw, 564px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Requerido para la Unidad de Consulta Externa de Enfermedades Recepci\u00f3n de ofertas 24 de agosto de 2021 a las 10:00 horas<\/p>\n","protected":false},"author":4,"featured_media":22476,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[215],"coauthors":[881],"class_list":{"0":"post-22475","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-convocatorias","8":"tag-convocatorias"},"_links":{"self":[{"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/posts\/22475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/comments?post=22475"}],"version-history":[{"count":1,"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/posts\/22475\/revisions"}],"predecessor-version":[{"id":22477,"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/posts\/22475\/revisions\/22477"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/media\/22476"}],"wp:attachment":[{"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/media?parent=22475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/categories?post=22475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/tags?post=22475"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.igssgt.org\/noticias\/wp-json\/wp\/v2\/coauthors?post=22475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}